Whilst Ozempic is generally well-tolerated, patients often have questions about sun exposure and potential skin reactions during treatment
Dementia, stroke, and survival A 2025 JAMA Network Open analysis of nearly 61,000 adults with type 2 diabetes and obesity found GLP-1 users had a ~37% lower risk of dementia, ~19% lower risk of stroke, and ~30% lower all-cause mortality than people on other diabetes drugs
To address this, alternative contraception options like IUDs or implants are often advised during treatment
And what he found was that they really run the gamut
Company 4 Zydus Lifesciences brings SEMAGLYNTM, MASHEMATM, and ALTERMET Zydus Lifesciences has introduced its generic version of semaglutide injection under the brand names SEMAGLYNTM, MASHEMATM, and ALTERMET